Balance Sheet AstraZeneca PLC

Equities

AZN

GB0009895292

Pharmaceuticals

Market Closed - London S.E. Other stock markets 11:35:29 2025-07-09 am EDT			5-day change	1st Jan Change
10,362.00 ^GBX	+0.21%		-0.38%	-1.01%

Jul. 09	Major deals involving U.S. drugmakers and biotechs over the past decade	RE
Jul. 09	Berenberg Lifts AstraZeneca Price Target, Earnings Forecasts on Drug Pipeline Strength	MT

b5d4ff8c87cfd3b0135d3b.dQBV6fBKEcmipDn-i-wJ4mXqT_7jtZHbM22fBMWD0No.N20anIgzIpzYyFfLuqVDgw6zLY-nhMaWeA7OR6exnrAANDqLyCRcs5bIXg

Published financial data: ASTRAZENECA PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	26.62B	37.42B	44.35B	45.81B	54.07B
Other Revenues, Total	-	-	-	-	-
Total Revenues	26.62B	37.42B	44.35B	45.81B	54.07B
Cost of Goods Sold, Total	5.25B	9.8B	8.62B	8.04B	9.64B
Gross Profit	21.37B	27.62B	35.73B	37.77B	44.44B
Selling General & Admin Expenses, Total	11.59B	14.46B	17.47B	18.02B	19.45B
R&D Expenses	6.12B	8.55B	9.53B	10.3B	12.24B
Other Operating Expenses	-486M	-207M	-231M	-987M	-190M
Other Operating Expenses, Total	17.22B	22.81B	26.77B	27.34B	31.51B
Operating Income	4.15B	4.81B	8.96B	10.43B	12.93B
Interest Expense, Total	-738M	-776M	-917M	-1.22B	-1.4B
Interest And Investment Income	77M	43M	81M	301M	345M
Net Interest Expenses	-661M	-733M	-836M	-918M	-1.06B
Income (Loss) On Equity Invest.	-27M	-64M	-5M	-12M	-28M
Currency Exchange Gains (Loss)	-34M	-20M	-16M	-34M	-42M
Other Non Operating Income (Expenses)	-487M	-478M	-370M	-292M	-134M
EBT, Excl. Unusual Items	2.94B	3.52B	7.74B	9.18B	11.67B
Restructuring Charges	-251M	-1.28B	-717M	-467M	-1.15B
Merger & Related Restructuring Charges	-	-2.44B	-3.57B	-137M	-
Gain (Loss) On Sale Of Investments	-	776M	-	-	-
Gain (Loss) On Sale Of Assets	1.06B	509M	216M	292M	60M
Asset Writedown	-252M	-2.07B	-241M	-434M	-1.57B
Legal Settlements	9M	-48M	-789M	-1.01B	-48M
Other Unusual Items	416M	774M	-133M	-520M	-260M
EBT, Incl. Unusual Items	3.92B	-265M	2.5B	6.9B	8.69B
Income Tax Expense	772M	-380M	-792M	938M	1.65B
Earnings From Continuing Operations	3.14B	115M	3.29B	5.96B	7.04B
Net Income to Company	3.14B	115M	3.29B	5.96B	7.04B
Minority Interest	52M	-3M	-5M	-6M	-6M
Net Income - (IS)	3.2B	112M	3.29B	5.96B	7.04B
Net Income to Common Incl Extra Items	3.2B	112M	3.29B	5.96B	7.04B
Net Income to Common Excl. Extra Items	3.2B	112M	3.29B	5.96B	7.04B
Per Share Items
Net EPS - Basic	2.44	0.08	2.12	3.84	4.54
Basic EPS - Continuing Operations	2.44	0.08	2.12	3.84	4.54
Basic Weighted Average Shares Outstanding	1.31B	1.42B	1.55B	1.55B	1.55B
Net EPS - Diluted	2.44	0.08	2.11	3.81	4.5
Diluted EPS - Continuing Operations	2.44	0.08	2.11	3.81	4.5
Diluted Weighted Average Shares Outstanding	1.31B	1.43B	1.56B	1.56B	1.56B
Normalized Basic EPS	1.44	1.55	3.12	3.7	4.7
Normalized Diluted EPS	1.44	1.54	3.1	3.67	4.66
Dividend Per Share	2.8	2.87	2.9	2.9	3.1
Payout Ratio	111.76	3.44K	132.72	75.25	65.8
American Depositary Receipts Ratio (ADR)	0.08	0.08	0.08	0.08	0.08
Supplemental Items
EBITDA	6.76B	8.62B	13.9B	15.01B	17.57B
EBITA	6.08B	7.89B	13.04B	14.28B	16.77B
EBIT	4.15B	4.81B	8.96B	10.43B	12.93B
EBITDAR	6.76B	8.62B	-	-	-
Total Revenues (As Reported)	26.62B	37.42B	44.35B	45.81B	54.07B
Effective Tax Rate - (Ratio)	19.71	143.4	-31.67	13.6	18.99
Total Current Taxes	971M	1.2B	1.64B	2.44B	2.44B
Total Deferred Taxes	-199M	-1.58B	-2.43B	-1.51B	-795M
Normalized Net Income	1.89B	2.2B	4.83B	5.73B	7.29B
Interest on Long-Term Debt	21M	22M	24M	33M	61M
Non-Cash Pension Expense	16M	38M	42M	37M	64M
Supplemental Operating Expense Items
Selling and Marketing Expenses	399M	446M	534M	539M	555M
Research And Development Expense From Footnotes	6.05B	9.82B	9.84B	11.02B	13.67B
Net Rental Expense, Total	-4M	6M	-	-	-
Imputed Operating Lease Interest Expense	-1.09M	1.33M	-	-	-
Imputed Operating Lease Depreciation	-2.91M	4.67M	-	-	-
Stock-Based Comp., Other (Total)	277M	615M	619M	579M	660M
Total Stock-Based Compensation	277M	615M	619M	579M	660M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	7.83B	6.33B	6.17B	5.84B	5.49B
Short Term Investments	42M	53M	64M	-	-
Trading Asset Securities, Total	161M	16M	14M	20M	37M
Total Cash And Short Term Investments	8.04B	6.4B	6.24B	5.86B	5.52B
Accounts Receivable, Total	3.81B	6.03B	7.21B	8.41B	8.3B
Other Receivables	1.84B	2.76B	2.71B	3.53B	4.79B
Total Receivables	5.65B	8.8B	9.92B	11.94B	13.09B
Inventory	4.02B	8.98B	4.7B	5.42B	5.29B
Prepaid Expenses	1.74B	1.51B	1.33B	1.62B	1.74B
Restricted Cash	-	-	162M	102M	129M
Other Current Assets, Total	99M	556M	236M	116M	54M
Total Current Assets	19.54B	26.24B	22.59B	25.05B	25.83B
Gross Property Plant And Equipment	17.11B	18.5B	17.19B	19.1B	20.52B
Accumulated Depreciation	-8.19B	-8.32B	-7.74B	-8.6B	-8.88B
Net Property Plant And Equipment	8.92B	10.17B	9.45B	10.5B	11.65B
Long-term Investments	1.19B	1.26B	1.14B	1.68B	1.9B
Goodwill	11.84B	20B	19.82B	20.05B	21.02B
Other Intangibles, Total	20.95B	42.39B	39.31B	38.09B	37.18B
Deferred Tax Assets Long-Term	3.44B	4.33B	3.26B	4.72B	5.35B
Other Long-Term Assets, Total	846M	972M	909M	1.03B	1.11B
Total Assets	66.73B	105B	96.48B	101B	104B
Liabilities
Accounts Payable, Total	2.35B	2.82B	2.55B	3.27B	3.64B
Accrued Expenses, Total	9.69B	12.36B	13.43B	15.74B	16.09B
Short-term Borrowings	661M	411M	5.31B	5.13B	330M
Current Portion of Long-Term Debt	1.57B	2.25B	960M	989M	2.06B
Current Portion of Leases	192M	233M	228M	271M	339M
Current Income Taxes Payable	1.13B	916M	896M	1.58B	1.41B
Unearned Revenue Current, Total	1.96B	1.18B	269M	251M	126M
Other Current Liabilities	2.76B	2.42B	2.65B	3.31B	3.88B
Total Current Liabilities	20.31B	22.59B	26.29B	30.54B	27.87B
Long-Term Debt	19.8B	29.72B	23.91B	22.4B	26.62B
Long-Term Leases	489M	754M	725M	857M	1.11B
Unearned Revenue Non Current	38M	26M	14M	7M	-
Pension & Other Post Retirement Benefits	3.2B	2.45B	1.17B	1.52B	1.33B
Deferred Tax Liability Non Current	2.92B	6.21B	2.94B	2.84B	3.3B
Other Non Current Liabilities	4.33B	4.32B	4.37B	3.78B	2.93B
Total Liabilities	51.09B	66.08B	59.42B	61.95B	63.16B
Common Stock, Total	328M	387M	387M	388M	388M
Additional Paid In Capital	7.97B	35.13B	35.16B	35.19B	35.23B
Retained Earnings	6.44B	3.64B	3.12B	4.52B	7.23B
Comprehensive Income and Other	881M	111M	-1.62B	-949M	-2.06B
Total Common Equity	15.62B	39.27B	37.04B	39.14B	40.79B
Minority Interest	16M	19M	21M	23M	85M
Total Equity	15.64B	39.29B	37.06B	39.17B	40.87B
Total Liabilities And Equity	66.73B	105B	96.48B	101B	104B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.31B	1.55B	1.55B	1.55B	1.55B
ECS Total Common Shares Outstanding	1.31B	1.55B	1.55B	1.55B	1.55B
Book Value / Share	11.9	25.34	23.9	25.25	26.3
Tangible Book Value	-17.17B	-23.12B	-22.09B	-18.99B	-17.42B
Tangible Book Value Per Share	-13.08	-14.92	-14.25	-12.25	-11.23
Total Debt	22.71B	33.36B	31.14B	29.65B	30.46B
Net Debt	14.68B	26.96B	24.89B	23.79B	24.94B
Debt Equivalent of Unfunded Proj. Benefit Obligation	3.23B	2.5B	1.12B	1.48B	1.27B
Debt Equivalent Oper. Leases	-32M	48M	-	-	-
Minority Interest, Total (Incl. Fin. Div)	16M	19M	21M	23M	85M
Equity Method Investments, Total	39M	69M	76M	147M	268M
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	1.26B	1.76B	1.42B	1.53B	1.49B
Inventories - Work In Process, Total	1.33B	5.22B	1.86B	2.32B	2.28B
Inventories - Finished Goods, Total	1.43B	2.01B	1.41B	1.57B	1.52B
Land - (BS)	5.85B	6.38B	5.44B	6.47B	6.58B
Machinery, Total	7.74B	7.9B	7.56B	8.7B	8.85B
Full Time Employees	76.1K	83.1K	83.5K	89.9K	94.3K
Accumulated Allowance for Doubtful Accounts (Supple)	23M	23M	59M	45M	33M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	3.2B	112M	3.29B	5.96B	7.04B
Depreciation & Amortization - CF	900M	959M	1.1B	1B	1.14B
Amortization of Goodwill and Intangible Assets - (CF)	1.93B	3.08B	4.08B	3.85B	3.84B
Depreciation & Amortization, Total	2.83B	4.04B	5.18B	4.85B	4.98B
Amortization of Deferred Charges, Total - (CF)	61M	63M	76M	280M	200M
(Gain) Loss From Sale Of Asset	-1.06B	-513M	-216M	-292M	-60M
(Gain) Loss on Sale of Investments - (CF)	-	-776M	-	-	-
Asset Writedown & Restructuring Costs	257M	2.43B	226M	456M	1.62B
(Income) Loss On Equity Investments - (CF)	27M	64M	5M	12M	28M
Stock-Based Compensation (CF)	-72M	45M	27M	-71M	42M
Other Operating Activities, Total	-807M	-1.52B	-2.53B	-1.15B	-1.1B
Change In Accounts Receivable	-739M	-961M	-1.35B	-1.42B	-1.62B
Change In Inventories	-621M	1.58B	3.94B	-669M	-131M
Change In Accounts Payable	1.72B	1.4B	1.16B	2.39B	862M
Cash from Operations	4.8B	5.96B	9.81B	10.34B	11.86B
Capital Expenditure	-961M	-1.09B	-1.09B	-1.36B	-1.92B
Sale of Property, Plant, and Equipment	106M	13M	282M	132M	55M
Cash Acquisitions	-822M	-10.12B	-1.04B	-1.1B	-3.78B
Sale (Purchase) of Intangible assets	-694M	-522M	-1.03B	-2.13B	-2.54B
Investment in Marketable and Equity Securities, Total	2B	605M	-143M	-87M	-133M
Other Investing Activities, Total	87M	54M	60M	477M	343M
Cash from Investing	-285M	-11.06B	-2.96B	-4.06B	-7.98B
Short Term Debt Issued, Total	288M	-	74M	161M	-
Long-Term Debt Issued, Total	2.97B	12.93B	-	3.82B	6.49B
Total Debt Issued	3.26B	12.93B	74M	3.98B	6.49B
Short Term Debt Repaid, Total	-	-276M	-	-	-31M
Long-Term Debt Repaid, Total	-1.82B	-5B	-1.52B	-5.21B	-4.97B
Total Debt Repaid	-1.82B	-5.28B	-1.52B	-5.21B	-5B
Issuance of Common Stock	30M	29M	29M	33M	38M
Repurchase of Common Stock	-	-	-	-	-81M
Common Dividends Paid	-3.57B	-3.86B	-4.36B	-4.48B	-4.63B
Common & Preferred Stock Dividends Paid	-3.57B	-3.86B	-4.36B	-4.48B	-4.63B
Other Financing Activities, Total	-101M	-178M	-1.05B	-886M	-817M
Cash from Financing	-2.2B	3.65B	-6.82B	-6.57B	-4B
Foreign Exchange Rate Adjustments	12M	-62M	-80M	-60M	-93M
Net Change in Cash	2.32B	-1.51B	-55M	-346M	-208M
Supplemental Items
Cash Interest Paid	733M	721M	849M	1.08B	1.31B
Cash Income Tax Paid (Refund)	1.56B	1.74B	1.62B	2.37B	2.75B
Levered Free Cash Flow	3.3B	-896M	12.36B	9.5B	8.46B
Unlevered Free Cash Flow	3.76B	-412M	12.94B	10.06B	9.22B
Change In Net Working Capital	347M	6.52B	-3.59B	-1.52B	121M
Net Debt Issued / Repaid	1.44B	7.65B	-1.44B	-1.23B	1.49B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	4.05	3.5	5.55	6.6	7.88
Return on Total Capital	7.07	5.42	7.95	9.52	11.53
Return On Equity %	20.8	0.42	8.63	15.64	17.59
Return on Common Equity	22.23	0.41	8.62	15.63	17.6
Margin Analysis
Gross Profit Margin %	80.29	73.81	80.57	82.45	82.18
SG&A Margin	43.53	38.65	39.39	39.35	35.98
EBITDA Margin %	25.41	23.03	31.33	32.76	32.49
EBITA Margin %	22.84	21.09	29.41	31.17	31.01
EBIT Margin %	15.58	12.86	20.21	22.78	23.91
Income From Continuing Operations Margin %	11.81	0.31	7.42	13.01	13.02
Net Income Margin %	12.01	0.3	7.41	13	13.01
Net Avail. For Common Margin %	12.01	0.3	7.41	13	13.01
Normalized Net Income Margin	7.1	5.87	10.89	12.51	13.47
Levered Free Cash Flow Margin	12.39	-2.4	27.88	20.74	15.65
Unlevered Free Cash Flow Margin	14.12	-1.1	29.17	21.96	17.05
Asset Turnover
Asset Turnover	0.42	0.43	0.44	0.46	0.53
Fixed Assets Turnover	3.09	3.92	4.52	4.59	4.88
Receivables Turnover (Average Receivables)	7.2	7.61	6.7	5.87	6.47
Inventory Turnover (Average Inventory)	1.45	1.51	1.26	1.59	1.8
Short Term Liquidity
Current Ratio	0.96	1.16	0.86	0.82	0.93
Quick Ratio	0.67	0.67	0.61	0.58	0.67
Operating Cash Flow to Current Liabilities	0.24	0.26	0.37	0.34	0.43
Days Sales Outstanding (Average Receivables)	50.82	47.98	54.49	62.22	56.55
Days Outstanding Inventory (Average Inventory)	251.76	242.25	289.7	229.78	203.39
Average Days Payable Outstanding	124.19	63.98	226.24	121.12	133.02
Cash Conversion Cycle (Average Days)	178.38	226.24	117.96	170.89	126.92
Long Term Solvency
Total Debt/Equity	145.24	84.92	84.02	75.7	74.53
Total Debt / Total Capital	59.22	45.92	45.66	43.08	42.7
LT Debt/Equity	129.77	77.56	66.47	59.39	67.86
Long-Term Debt / Total Capital	52.92	41.94	36.12	33.8	38.88
Total Liabilities / Total Assets	76.56	62.71	61.59	61.27	60.71
EBIT / Interest Expense	5.62	6.2	9.77	8.56	9.22
EBITDA / Interest Expense	9.46	11.41	15.42	12.54	12.77
(EBITDA - Capex) / Interest Expense	8.15	10	14.23	11.42	11.39
Total Debt / EBITDA	3.25	3.77	2.2	1.94	1.7
Net Debt / EBITDA	2.1	3.05	1.76	1.56	1.39
Total Debt / (EBITDA - Capex)	3.77	4.3	2.39	2.13	1.91
Net Debt / (EBITDA - Capex)	2.44	3.47	1.91	1.71	1.56
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	9.16	40.58	18.53	3.29	18.03
Gross Profit, 1 Yr. Growth %	9.39	29.23	29.38	5.71	17.64
EBITDA, 1 Yr. Growth %	21.02	27.3	51.91	7.64	23.5
EBITA, 1 Yr. Growth %	23.36	29.82	54.85	9.07	24.26
EBIT, 1 Yr. Growth %	35.2	16.01	67.75	15.78	34.01
Earnings From Cont. Operations, 1 Yr. Growth %	156.23	-96.34	2.76K	81.02	18.12
Net Income, 1 Yr. Growth %	139.4	-96.5	2.84K	81.11	18.14
Normalized Net Income, 1 Yr. Growth %	57.59	16.21	91.14	17.89	39.07
Diluted EPS Before Extra, 1 Yr. Growth %	137.39	-96.76	2.57K	80.57	18.11
Accounts Receivable, 1 Yr. Growth %	6.16	58.46	19.58	16.57	-1.25
Inventory, 1 Yr. Growth %	26.03	123.24	-47.69	15.43	-2.51
Net Property, Plant and Equip., 1 Yr. Growth %	6.98	14.06	-7.1	11.14	10.9
Total Assets, 1 Yr. Growth %	8.72	57.9	-8.43	4.8	2.88
Tangible Book Value, 1 Yr. Growth %	-11.38	34.63	-4.44	-14.02	-8.31
Common Equity, 1 Yr. Growth %	19.01	151.36	-5.68	5.69	4.2
Cash From Operations, 1 Yr. Growth %	61.64	24.26	64.48	5.48	14.65
Capital Expenditures, 1 Yr. Growth %	-1.84	13.53	0	24.75	41.37
Levered Free Cash Flow, 1 Yr. Growth %	-47.03	-127.15	-2.29K	-24.67	-6.08
Unlevered Free Cash Flow, 1 Yr. Growth %	-44.01	-110.93	-16.35K	-22.41	-3.64
Dividend Per Share, 1 Yr. Growth %	0	2.5	1.05	0	6.9
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	9.77	23.87	29.08	10.65	10.42
Gross Profit, 2 Yr. CAGR %	10.24	18.9	29.31	21.92	11.55
EBITDA, 2 Yr. CAGR %	23.12	24.32	40.99	49.67	13.06
EBITA, 2 Yr. CAGR %	26.22	26.55	43.87	54.57	14.05
EBIT, 2 Yr. CAGR %	54.8	25.24	43.21	89.78	21.13
Earnings From Cont. Operations, 2 Yr. CAGR %	23.84	-69.39	2.34	619.96	46.22
Net Income, 2 Yr. CAGR %	21.78	-71.04	1.43	629.18	46.27
Normalized Net Income, 2 Yr. CAGR %	132.93	35.33	54.34	139.59	24.04
Diluted EPS Before Extra, 2 Yr. CAGR %	19.7	-72.26	-6.93	594.53	46.04
Accounts Receivable, 2 Yr. CAGR %	12.73	29.7	37.66	18.07	7.29
Inventory, 2 Yr. CAGR %	18	67.73	8.06	-22.3	6.08
Net Property, Plant and Equip., 2 Yr. CAGR %	9.62	10.47	2.94	1.61	11.02
Total Assets, 2 Yr. CAGR %	4.89	31.02	20.25	-2.03	3.84
Tangible Book Value, 2 Yr. CAGR %	-10	9.23	13.43	-9.35	-11.21
Common Equity, 2 Yr. CAGR %	11.94	72.96	53.97	-0.16	4.94
Cash From Operations, 2 Yr. CAGR %	35.39	41.72	42.96	31.71	9.97
Capital Expenditures, 2 Yr. CAGR %	-4.01	5.57	6.55	11.69	32.8
Levered Free Cash Flow, 2 Yr. CAGR %	-5.56	-62.01	89.55	126.88	-17.68
Unlevered Free Cash Flow, 2 Yr. CAGR %	-4.97	-75.22	82.08	150.11	-15.26
Dividend Per Share, 2 Yr. CAGR %	0	1.24	1.77	0.52	3.39
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.82	19.2	22.07	19.84	13.06
Gross Profit, 3 Yr. CAGR %	5.25	16.24	22.29	20.91	20.47
EBITDA, 3 Yr. CAGR %	4.04	24.53	35.58	29.01	37.89
EBITA, 3 Yr. CAGR %	3.83	27.41	38.33	31.35	41.04
EBIT, 3 Yr. CAGR %	4.01	40.61	42.96	33.66	64.64
Earnings From Cont. Operations, 3 Yr. CAGR %	3.11	-61.72	38.97	23.77	294.14
Net Income, 3 Yr. CAGR %	2.12	-62.68	35.05	23.05	297.51
Normalized Net Income, 3 Yr. CAGR %	6.56	84.75	59.13	41.38	93.98
Diluted EPS Before Extra, 3 Yr. CAGR %	0.92	-64.05	27.16	16.08	284.79
Accounts Receivable, 3 Yr. CAGR %	10.75	26.28	26.24	30.23	11.24
Inventory, 3 Yr. CAGR %	9.86	45.94	13.75	10.46	-16.19
Net Property, Plant and Equip., 3 Yr. CAGR %	5.4	11.08	4.27	5.6	4.62
Total Assets, 3 Yr. CAGR %	1.75	20.21	16.27	14.86	-0.42
Tangible Book Value, 3 Yr. CAGR %	-9.35	2.93	4.47	3.42	-9.01
Common Equity, 3 Yr. CAGR %	1.45	46.58	41.3	35.82	1.27
Cash From Operations, 3 Yr. CAGR %	10.28	31.57	48.93	29.18	25.76
Capital Expenditures, 3 Yr. CAGR %	-10.18	1.51	3.68	12.3	20.82
Levered Free Cash Flow, 3 Yr. CAGR %	-7.7	-37.65	25.78	40.28	66.13
Unlevered Free Cash Flow, 3 Yr. CAGR %	-6.57	-53.76	24.52	37.12	78.98
Dividend Per Share, 3 Yr. CAGR %	0	0.83	1.18	1.18	2.6
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.5	10.22	14.57	15.71	17.27
Gross Profit, 5 Yr. CAGR %	1.11	7.76	14.28	16.52	17.86
EBITDA, 5 Yr. CAGR %	0.53	7.2	18.26	27.46	25.8
EBITA, 5 Yr. CAGR %	0.39	7.4	19.15	30.2	27.75
EBIT, 5 Yr. CAGR %	0.38	4.26	19.45	43.23	33.33
Earnings From Cont. Operations, 5 Yr. CAGR %	2.16	-49.22	2.8	23.8	41.83
Net Income, 5 Yr. CAGR %	2.5	-49.76	1.84	22.54	39.43
Normalized Net Income, 5 Yr. CAGR %	-0.52	4.88	25.34	75.1	43.47
Diluted EPS Before Extra, 5 Yr. CAGR %	1.78	-50.87	-2.3	17.52	34.4
Accounts Receivable, 5 Yr. CAGR %	-3.86	18.48	20.81	22.93	18.29
Inventory, 5 Yr. CAGR %	13.43	30.94	9.14	13.42	10.62
Net Property, Plant and Equip., 5 Yr. CAGR %	6.81	8.23	4.41	7.19	6.92
Total Assets, 5 Yr. CAGR %	2.13	11	8.78	10.76	11.13
Tangible Book Value, 5 Yr. CAGR %	1.48	-1.07	-0.85	-2.17	-2.11
Common Equity, 5 Yr. CAGR %	-3.31	21.46	19.88	25.71	25.45
Cash From Operations, 5 Yr. CAGR %	7.62	7.54	22.35	31.63	31.92
Capital Expenditures, 5 Yr. CAGR %	-6.26	-5.48	-3.83	5.47	14.47
Levered Free Cash Flow, 5 Yr. CAGR %	-2.37	-27.5	24.13	20.77	6.37
Unlevered Free Cash Flow, 5 Yr. CAGR %	-1.06	-38.97	22.92	19.3	6.6
Dividend Per Share, 5 Yr. CAGR %	0	0.5	0.7	0.7	2.06